参考文献:1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137鈥?0. CrossRef 2. Ajani JA, Barthel JS, Bentrem DJ, D鈥橝mico TA, Das P, Denlinger CS, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw. 2011;9(8):830鈥?7. 3. Edge SB. American Joint Committee on Cancer: AJCC cancer staging manual. 7th ed. New York: Springer; 2010. 4. Li B, Chen H, Xiang J, Zhang Y, Li C, Hu H, et al. Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg. 2012;144(4):778鈥?6. CrossRef 5. Tanaka H, Ohira M, Kubo N, Muguruma K, Yamashita Y, Sawada T, et al. Association of location of lymph node metastases with postoperative recurrence of esophageal squamous cell carcinoma. Anticancer Res. 2012;32(8):3421鈥?. 6. Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shimizu T, et al. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg. 2006;30(8):1441鈥?. CrossRef 7. Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shuto K, et al. Location and clinical impact of solitary lymph node metastasis in patients with thoracic esophageal carcinoma. Am J Surg. 2006;192(3):306鈥?0. CrossRef 8. Kunisaki C, Makino H, Kimura J, Oshima T, Fujii S, Takagawa R, et al. Impact of lymph-node metastasis site in patients with thoracic esophageal cancer. J Surg Oncol. 2010;101(1):36鈥?2. CrossRef 9. Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg. 2004;239(4):483鈥?0. CrossRef 10. Martin DJ, Church NG, Kennedy CW, Falk GL. Does systematic 2-field lymphadenectomy for esophageal malignancy offer a survival advantage? Results from 178 consecutive patients. Dis Esophagus. 2008;21(7):612鈥?. CrossRef 11. Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg. 1998;175(1):47鈥?1. CrossRef 12. Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, Iwatsuki M, et al. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery. 2012. doi:10.1016/S0039-60 60(12) 00442-4. 13. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112(6):1239鈥?6. CrossRef 14. Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248(4):549鈥?6. 15. Hsu WH, Hsu PK, Hsieh CC, Huang CS, Wu YC. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg. 2009;13(11):1913鈥?0. CrossRef 16. Chao YK, Liu HP, Hsieh MJ, Wu YC, Liu YH, Yeh CH, et al. Impact of the number of lymph nodes sampled on outcome in ypT0N0 esophageal squamous cell carcinoma patients. J Surg Oncol. 2012;106(4):436鈥?0. CrossRef 17. Bogoevski D, Onken F, Koenig A, Kaifi JT, Schurr P, Sauter G, et al. Is it time for a new TNM classification in esophageal carcinoma? Ann Surg. 2008;247(4):633鈥?1. CrossRef 18. Groth SS, Virnig BA, Whitson BA, DeFor TE, Li ZZ, Tuttle TM, et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg. 2010;139(3):612鈥?0. CrossRef 19. Yang HX, Xu Y, Fu JH, Wang JY, Lin P, Rong TH. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China. Ann Surg Oncol. 2010;17(7):1901鈥?1. CrossRef 20. Liu YP, Ma L, Wang SJ, Chen YN, Wu GX, Han M, et al. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma. Eur J Surg Oncol. 2010;36(2):155鈥? CrossRef 21. Kelty CJ, Kennedy CW, Falk GL. Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol. 2010;5(9):1467鈥?1. CrossRef 22. Wu J, Chen QX, Zhou XM, Mao WM, Krasna MJ, Teng LS. Prognostic significance of solitary lymph node metastasis in patients with squamous cell carcinoma of middlethoracic esophagus. World J Surg Oncol. 2012;10(1):210. CrossRef 23. Kunisaki C, Makino H, Kimura J, Oshima T, Fujii S, Takagawa R, et al. Therapeutic strategy for esophageal cancer based on solitary lymph node metastasis. Hepatogastroenterology. 2011;58(110鈥?11):1561鈥?. 24. Sakai M, Suzuki S, Sano A, Tanaka N, Inose T, Sohda M, et al. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19(6):1911鈥?. CrossRef
作者单位:Ning Wu MD (1) Zhiming Chen MD (1) Liewen Pang MD (1) Qinyun Ma (1) Gang Chen (1)
1. Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University, 200040, Shanghai, P.R. China